FactoryRegistry
Claim a page

Manufacturing of other pharmaceutical preparations affecting neoplasms, the endocrine system, and metabolic diseases, for human use

1 INDUSTRIES
IndustryEstablishmentsShare of industry

Withheld means Census suppressed the figure because publishing it would disclose an individual establishment. The line itself is never suppressed — only the numbers on it.

The U.S. Census Bureau recorded this product line in 1 US manufacturing industry in the 2022 Economic Census, as the most specific line that industry reported, where 130 establishments reported producing it.

These are counts of establishments by industry: the Economic Census publishes them as industry totals and never as a list of plants.

Related lines
Manufacturing of androgenic hormone preparations, excluding anabolic agentsManufacturing of anti-neoplastic agents, including radioactive isotopes, and specific anti-neoplastic agentsManufacturing of estrogenic hormone preparationsManufacturing of insulin and antidiabetic agentsManufacturing of oral contraceptive preparationsManufacturing of other hormone preparations, including sex hormone combinations, ACTH and anabolic agents, excluding progestogen combinationsManufacturing of progestogens, excluding premenstrual tension preparationsManufacturing of systemic, local, and topical corticoid hormone preparations, including anti-infective combinationsManufacturing of thyroid and anti-thyroid preparations, including iodides and propylthiouracil
Industries
Chemical ManufacturersAll product lines

NAPCS collection code 2010150031. Source for the product line, the establishment counts and the shares: U.S. Census Bureau, 2022 Economic Census (ECNNAPCSIND2022). Federal source data is public domain. Facility records are compiled separately by FactoryRegistry and carry their own sources.